Intravitreal bevacizumab treatment for refractory diabetic macular edema

International Ophthalmology

Volumn 33, Issue 6, 2013, Pages 659-663

  Yuksel, Erdem ^a   Ozdek, Sengul ^b   Yuksel, Nilay ^a   Hasanreisoglu, Berati ^b  

^a Kahramanmaras State Hospital   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Central retinal thickness; Diabetic retinopathy; Intravitreal bevacizumab; Refractory diabetic macular edema; VEGF

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETONIDE; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; DIABETIC MACULAR EDEMA; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA FOVEA; RETINAL THICKNESS; RETROSPECTIVE STUDY; SLIT LAMP; TREATMENT FAILURE; TREATMENT RESPONSE; VISION; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; AGED; DIABETIC RETINOPATHY; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84890192275     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-013-9758-y     Document Type: Article

References (23)

1. Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR (2007) A phase ii randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 114:1860-1867 (Pubitemid 46829374)
2. Rotsos TG, Moschos MM (2008) Cystoid macular edema. J Clin Ophthalmol 2:919-930
3. Early treatment diabetic retinopathy study research group (1985) Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 10:1796-1806
4. Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57-61 (Pubitemid 36401766)
5. Norlaili M, Bakiah S, Zunaina E (2011) Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study. BMC Ophthalmol 11:36
6. Shimura M, Yasuda K, Nakazawa T, Hirano Y, Sakamoto T, Ogura Y, Shiono T (2011) Visual outcome after intravitreal triamcinolone acetonide depends on optical coherence tomographic patterns in patients with diffuse diabetic macular edema. Retina 31:748-754
7. Sampat KM, Garg SJ (2010) Complications of intravitreal injections. Curr Opin Ophthalmol 21:178-183
8. Qaum T, Xu Q, Joussen AM, Clemens MW, Qin W, Miyamoto K, Hassessian H, Wiegand SJ, Rudge J, Yancopoulos GD, Adamis AP (2001) VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 42:2408-2413 (Pubitemid 32848873)
9. Tolentino MJ, McLeod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA (2002) Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am J Ophthalmol 133:373-385 (Pubitemid 34171588)
10. Zhou J, Wang S, Xia X (2012) Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy. Curr Eye Res 37:416-420
11. Funk M, Schmidinger G, Maar N, Bolz M, Benesch T, Zlabinger GJ, Schmidt-Erfurth UM (2010) Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 30:1412-1419
12. Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A (2006) Intravitreal bevacizumab (avastin) therapy for persistent diffuse diabetic macular edema. Retina 26:999-1005 (Pubitemid 44973218)
13. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME (2007) Primary intravitreal bevacizumab (avastin) for diabetic macular edema: Results from the pan-american collaborative retina study group at 6-month follow-up. Ophthalmology 114:743-750 (Pubitemid 46483714)
14. Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C (2008) Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina 28:1053-1060
15. Fang X, Sakaguchi H, Gomi F, Oshima Y, Sawa M, Tsujikawa M, Ikuno Y, Kamei M, Kusaka S, Tano Y (2008) Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema. Acta Ophthalmol 86:800-805
16. Roh MI, Byeon SH, Kwon OW (2008) Repeated intravitreal injection of bevacizumab for clinically significant diabetic macular edema. Retina 28:1314-1318
17. Stewart MW (2007) Predicted biologic activity of intravitreal bevacizumab. Retina 27:1196-1200 (Pubitemid 350211524)
18. Bakri SJ, Snyder MR, Reid JM, Pulido JS, Singh RJ (2007) Pharmacokinetics of intravitreal bevacizumab (avastin). Ophthalmology 114:855-859 (Pubitemid 46635858)
19. Welch DE, Elmariah H, Peden MC, Adams SG, Ratnakaram R, Kaushal S (2009) Short-term response of macular oedema to intravitreal bevacizumab. Br J Ophthalmol 93:1033-1036
20. Biester S, Ziemssen F, Ulrich Bartz-Schmidt K, Gelisken F (2009) Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema? Graefes Arch Clin Exp Ophthalmol 247:1575-1577
21. Adamis AP, Miller JW, Bernal MT, D'Amico DJ, Folkman J, Yeo TK, Yeo KT (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445-450 (Pubitemid 24307211)
22. Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Group (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119:789-801
23. Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A, RESTORE study group (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118:615-625